Citadel Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-42,956
| Closed | -$2.06M | – | 5654 |
|
|
2020
Q1 | $2.06M | Sell |
42,956
-749,915
| -95% | -$36M | ﹤0.01% | 2192 |
|
|
2019
Q4 | $37.2M | Buy |
792,871
+681,925
| +615% | +$32M | 0.02% | 543 |
|
|
2019
Q3 | $2.62M | Buy |
+110,946
| New | +$2.62M | ﹤0.01% | 2148 |
|
|
2019
Q2 | – | Sell |
-339,544
| Closed | -$7.61M | – | 5342 |
|
|
2019
Q1 | $7.61M | Sell |
339,544
-748,926
| -69% | -$16.8M | ﹤0.01% | 1294 |
|
|
2018
Q4 | $19.8M | Buy |
1,088,470
+759,445
| +231% | +$13.8M | 0.01% | 690 |
|
|
2018
Q3 | $5.95M | Sell |
329,025
-20,176
| -6% | -$365K | ﹤0.01% | 1413 |
|
|
2018
Q2 | $3.48M | Buy |
349,201
+18,754
| +6% | +$187K | ﹤0.01% | 1707 |
|
|
2018
Q1 | $1.75M | Buy |
330,447
+30,980
| +10% | +$164K | ﹤0.01% | 2038 |
|
|
2017
Q4 | $2.55M | Sell |
299,467
-19,947
| -6% | -$170K | ﹤0.01% | 1739 |
|
|
2017
Q3 | $4.66M | Buy |
+319,414
| New | +$4.66M | ﹤0.01% | 1307 |
|